172 related articles for article (PubMed ID: 25122196)
21. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells.
Abe W; Nasu K; Nakada C; Kawano Y; Moriyama M; Narahara H
Hum Reprod; 2013 Mar; 28(3):750-61. PubMed ID: 23293219
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units.
Gobbi H; Dupont WD; Parl FF; Schuyler PA; Plummer WD; Olson SJ; Page DL
Int J Cancer; 2005 Feb; 113(5):857-9. PubMed ID: 15499614
[TBL] [Abstract][Full Text] [Related]
23. Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.
Sun X; Xu C; Tang SC; Wang J; Wang H; Wang P; Du N; Qin S; Li G; Xu S; Tao Z; Liu D; Ren H
Cancer Gene Ther; 2016 Apr; 23(4):83-9. PubMed ID: 26987290
[TBL] [Abstract][Full Text] [Related]
24. Does flat epithelial atypia have rounder nuclei than columnar cell change/hyperplasia? A morphometric approach to columnar cell lesions of the breast.
Yamashita Y; Ichihara S; Moritani S; Yoon HS; Yamaguchi M
Virchows Arch; 2016 Jun; 468(6):663-73. PubMed ID: 27026270
[TBL] [Abstract][Full Text] [Related]
25. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
26. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
27. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
[TBL] [Abstract][Full Text] [Related]
28. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture.
Dong-Le Bourhis X; Berthois Y; Millot G; Degeorges A; Sylvi M; Martin PM; Calvo F
Int J Cancer; 1997 Mar; 71(1):42-8. PubMed ID: 9096664
[TBL] [Abstract][Full Text] [Related]
29. Profiling of estrogen-regulated microRNAs in breast cancer cells.
Katchy A; Williams C
J Vis Exp; 2014 Feb; (84):e51285. PubMed ID: 24637950
[TBL] [Abstract][Full Text] [Related]
30. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study.
McLaren BK; Gobbi H; Schuyler PA; Olson SJ; Parl FF; Dupont WD; Page DL
Am J Surg Pathol; 2005 Jan; 29(1):105-8. PubMed ID: 15613861
[TBL] [Abstract][Full Text] [Related]
32. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.
Abdel-Fatah TM; Powe DG; Hodi Z; Lee AH; Reis-Filho JS; Ellis IO
Am J Surg Pathol; 2007 Mar; 31(3):417-26. PubMed ID: 17325484
[TBL] [Abstract][Full Text] [Related]
33. Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.
Bailey ST; Westerling T; Brown M
Cancer Res; 2015 Jan; 75(2):436-45. PubMed ID: 25388283
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide small RNA sequencing and gene expression analysis reveals a microRNA profile of cancer susceptibility in ATM-deficient human mammary epithelial cells.
Hesse JE; Liu L; Innes CL; Cui Y; Palii SS; Paules RS
PLoS One; 2013; 8(5):e64779. PubMed ID: 23741392
[TBL] [Abstract][Full Text] [Related]
35. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.
Spolverini A; Fuchs G; Bublik DR; Oren M
Oncogene; 2017 Oct; 36(42):5819-5828. PubMed ID: 28604753
[TBL] [Abstract][Full Text] [Related]
36. Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells.
Luciani MG; Seok J; Sayeed A; Champion S; Goodson WH; Jeffrey SS; Xiao W; Mindrinos M; Davis RW; Dairkee SH
PLoS One; 2011; 6(5):e20016. PubMed ID: 21625507
[TBL] [Abstract][Full Text] [Related]
37. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
Sempere LF; Christensen M; Silahtaroglu A; Bak M; Heath CV; Schwartz G; Wells W; Kauppinen S; Cole CN
Cancer Res; 2007 Dec; 67(24):11612-20. PubMed ID: 18089790
[TBL] [Abstract][Full Text] [Related]
38. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
[TBL] [Abstract][Full Text] [Related]
39. Loss of Estrogen-Regulated
Zhang W; Wu M; Chong QY; Zhang M; Zhang X; Hu L; Zhong Y; Qian P; Kong X; Tan S; Li G; Ding K; Lobie PE; Zhu T
Cancer Res; 2018 Sep; 78(17):4915-4928. PubMed ID: 29945962
[TBL] [Abstract][Full Text] [Related]
40. Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.
Cascione L; Gasparini P; Lovat F; Carasi S; Pulvirenti A; Ferro A; Alder H; He G; Vecchione A; Croce CM; Shapiro CL; Huebner K
PLoS One; 2013; 8(2):e55910. PubMed ID: 23405235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
